As filed with the Securities and Exchange Commission on March 9, 2022
Registration No. 333-
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Oncorus, Inc.
(Exact
name of Registrant as specified in its charter)
|
|
|
| Delaware
(State or other jurisdiction of
incorporation or organization) |
|
47-3779757
(I.R.S. Employer
Identification No.) |
50 Hampshire Street, Suite 401
Cambridge, Massachusetts 02139
(Address of principal executive offices) (Zip code)
Oncorus, Inc. 2020 Equity Incentive Plan
(Full title of the plan)
Theodore (Ted) Ashburn, M.D., PhD.
President and Chief Executive Officer
Oncorus, Inc.
50
Hampshire Street, Suite 401
Cambridge, Massachusetts 02139
Tel: (857) 320-6400
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
|
|
| Marc A. Recht
Brian F. Leaf Courtney T.
Thorne Cooley LLP
500 Boylston Street Boston,
Massachusetts 02116 (617)
937-2300 |
|
Brian J. Shea
Director, Legal Counsel and Secretary
Oncorus, Inc. 50
Hampshire Street, Suite 401 Cambridge, Massachusetts 02139
(857) 320-6400 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
| Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
|
| Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐